A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets
A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets
High Incidence of Infectious Diseases Persists, While Treatment Options Remain Scarce
RELEASE DATE
15-Oct-2013
15-Oct-2013
REGION
Global
Global
Research Code: ND3B-01-00-00-00
SKU: LS00226-GL-MR_17554
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
LS00226-GL-MR_17554
Description
Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well as drugs in clinical trial, is given for each disease type. Key statistics include the relative prevalence of each disease in Latin America. Conclusions and recommendations are also provided. The base year is 2012, with some timelines extending to 2018.
Table of Contents
Analysis of the Latin American Therapeutics Market for Infectious Diseases
- Therapeutics Market for Infectious Diseases in Latin America
Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well as drugs in clinical trial, is given for each disease type. Key statistics include the relative prevalence of each disease in Latin America. Conclusions and recommendations are also provided. The base year is 2012, with some timelines extending to 2018.
No Index | Yes |
---|---|
Podcast | No |
Author | Lucila Rocca |
WIP Number | ND3B-01-00-00-00 |
Is Prebook | No |